On Friday, Merck and Ridgeback announced their plan to seek Emergency Use Authorization (EUA) for Molnupiravir, an investigational oral antiviral drug for COVID-19 that was discovered by researchers at Emory University. On Oct. 5, 2021, Emory University President Gregory L. Fenves sat down with Emory's Dr. Jodie Guest to discuss Molnupiravir within the larger context of Emory's research eminence. Emory has in the past advanced the development of some of the world’s most important and valuable antiviral drugs, successfully taking treatments from bench to bedside.